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Abstract
Introduction: Soluble amyloid precursor protein a (sAPPa) is a proteolyte of APP cleavage by a-secretase. The
significance of the cleavage and the physiological role of sAPPa are unknown. A crystal structure of a region of the
amino terminal of sAPPa reveals a domain that is similar to cysteine-rich growth factors. While a previous study
implicates sAPPa in the regulation of neural progenitor cell proliferation in the subventricular zone of adult mice,
the ubiquitous expression of APP suggests that its role as a growth factor might be broader.
Methods: sAPPa and a-secretase activities were determined in neural progenitor cells (NPCs), mesenchymal stem
cells (MSC) and human decidua parietalis placenta stem cells (hdPSC). Inhibition of a-secretase was achieved by
treatment with the matrixmetalloproteinase inhibitor GM6001, and proliferation was determined using clonogenic
and immunocytochemical analysis of cell-lineage markers. Recovery of proliferation was achieved by
supplementing GM6001-treated cells with recombinant soluble APPa. Expression of APP and its cellular localization
in the subventricular zone was determined by Western blot and immunohistochemical analyses of APP wild type
and knockout tissue. Alterations in pERK and pAKT expression as a function of soluble APPa production and
activity in NPCs were determined by Western blot analysis.
Results: Here we show that sAPPa is a proliferation factor of adult NPCs, MSCs and hdpPSC. Inhibition of a-
secretase activity reduces proliferation of these stem cell populations in a dose-dependent manner. Stem cell
proliferation can be recovered by the addition of sAPPa in a dose-dependent manner, but not of media depleted
of sAPPa. Importantly, sAPPa operates independently of the prominent proliferation factors epidermal growth
factor (EGF) and basic fibroblast growth factor (bFGF), but in association with ERK signaling and MAP-kinase
signaling pathways. Levels of sAPPa and putative a-secretase, ADAM10, are particularly high in the subventricular
zone of adult mice, suggesting a role for sAPPa in regulation of NPCs in this microenvironment.
Conclusions: These results determine a physiological function for sAPPa and identify a new proliferation factor of
progenitor cells of ectodermal and mesodermal origin. Further, our studies elucidate a potential pathway for sAPPa
signaling through MAP kinase activation.
Introduction
Amyloid precursor proteins (APPs) comprise a family of
evolutionarily conserved single-pass type I transmem-
brane glycoproteins of an unknown physiological func-
tion. In mammals, that family includes APP and
amyloid precursor-like protein 1 and 2 (APLP1 and
APLP2) (reviewed in [1]). Mutations in APP cause
familial Alzheimer’s disease (reviewed in [1]). APP
undergoes extensive enzymatic processing, producing
both intracellular and extracellular metabolites (reviewed
in [2]). In its non-amyloidogenic pathway, APP is
cleaved mostly on the plasma membrane by an enzy-
matic activity termed the a-secretase [3,4]. a-Secretase
cleaves APP between Lys16 and Leu17 of the Ab region,
resulting in the release of a soluble fragment (sAPPa)t o
the extracellular lumen and the retention of a mem-
brane-tethered carboxyl-terminus fragment that under-
goes further proteolysis (reviewed in [5]). The identity
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any medium, provided the original work is properly cited.of a-secretase is not fully elucidated. Several enzymes-
including members of the ADAM (a disintegrin and
metalloproteinase) family ADAM10 [6], ADAM17
(TACE) [6-9], and ADAM9 as well as aspartyl protease
beta-site APP-cleaving enzyme 2 (BACE2) [10]-are
known to have a-secretase activity. Like APP, APLP2 is
a substrate of ADAM10 and 17 [11]. Both ADAM10
and 17 are implicated in development-regulated notch
signaling by ectodomain shedding of Notch ligands
Delta and Jagged [12]. ADAM10 was recently suggested
to be the main a-secretase in the brain [13].
sAPPa has been shown to exhibit neurotrophic and
proliferative properties in fibroblasts [14], thyroid
epithelial cells [15], and embryonic stem cells [16]. A
crystal structure of a region of the amino terminal of
sAPPa also reveals a domain that is similar to cysteine-
rich growth factors, suggesting that sAPPa may act as a
potential ligand for growth factor receptors [17]. Indeed,
epidermal growth factor (EGF)-responsive neural pro-
genitor cells (NPCs) in the subventricular zone (SVZ)
have been shown to have binding sites for sAPP [18].
Deficiency of the sortilin-related receptor with type-A
repeats (SORLA) results in enhancement of sAPP pro-
duction, extracellular signal-regulated kinase (ERK) sti-
mulation, and increased proliferation and survival of
NPCs in both the SVZ and subgranular layer of the den-
tate gyrus (SGL) [19]. Taken together, these results sug-
gest that APP may act as a growth factor in promoting
cellular proliferation. However, there has been no fol-
low-up to these studies. It is not clear what populations
of NPCs sAPPa acts upon, whether it is a stand-alone
factor or a co-factor, or whether it regulates non-neural
adult stem cell populations.
Here, we show that the production of sAPPa by a-
secretase processing of APP is an important event for
the promotion of proliferation in a wide range of stem
cell populations. We show, specifically, that sAPPa reg-
ulates the proliferation of NPCs, mesenchymal stem
cells (MSCs), and Human decidua parietalis placenta
stem cells (hdpPSCs). Importantly, sAPPa is a stand-
alone proliferation factor, exerting its proliferative effect
in an EGF- and basic fibroblast growth factor (bFGF)-
independent manner. In the brain, levels of sAPPa are
particularly high in the SVZ. In addition, we show that,
in NPCs, sAPPa function is associated with the ERK
signaling pathway. These results suggest that sAPPa is
an essential proliferation factor for neural and non-
neural adult stem cells. These observations further pro-
vide a functional significance for the abundance of APP.
Materials and methods
Primary neurosphere culture
Two-month-old C57/Bl6 wild-type mice were eutha-
nized and their brains were removed and placed into
sterile Dulbecco’s modified Eagle’sm e d i u m / F 1 2
(DMEM/F12). A coronal slice (approximately 1 mm)
was dissected starting 1 to 2 mm posterior to the olfac-
tory bulb. The region occupying the lateral wall and
anterior horn of the lateral ventricles was removed with
the aid of a dissecting microscope and diced with a ster-
ile scalpel. Neurosphere culture was prepared as pre-
viously described [20]. Briefly, tissue pieces were
collected in a mixture of Papain and DNase in Earl’s
balanced salt solution and incubated at 37°C for 40 min-
utes. Then, tissue pieces were pelleted by centrifugation
and dissociated to a single-cell suspension, and cells
were plated in complete medium-water, DMEM/F12
(Gibco, now part of Invitrogen Corporation, Carlsbad,
CA, USA), glucose (Sigma-Aldrich, St. Louis, MO,
USA), NaHCO3 (Sigma-Aldrich), HEPES (Sigma-
Aldrich), L-glutamine (Invitrogen Corporation), penicil-
lin/streptomycin (Invitrogen Corporation), putrescine
(9.6 μg/mL; Sigma-Aldrich), apotransferrin (0.1 mg/mL;
Sigma-Aldrich), insulin (0.025 mg/mL; Roche, Indiana-
polis, IN, USA), selenium (5.2 ng/mL; Sigma-Aldrich),
progesterone (6.3 ng/mL; Sigma-Aldrich), bovine serum
albumin (BSA) (2 mg/mL; Sigma-Aldrich), heparin (4
μg/mL; Sigma-Aldrich), EGF (20 ng/mL; PeproTech,
Rocky Hill, NJ, USA), and bFGF (10 ng/mL; Pepro-
Tech)-and passaged after 10 days.
Isolation of mesenchymal stem cells
After euthanasia, the bone marrow contents of the
femurs and tibia of donor Balb/C mice were flushed
through a 40-μm filter (Becton, Dickinson and Com-
p a n y ,F r a n k l i nL a k e s ,N J ,U S A )i n t oa5 0 - m Lt u b e
(Corning, Corning, NY, USA) containing MSC media:
40% alpha-modified Eagle’s medium (Invitrogen Cor-
poration, Rockville, MD, USA), 40% F-12 nutrient mix-
ture (Invitrogen Corporation), 10% fetal bovine serum
(Valley Biomedical, Winchester, VA, USA), and 1% anti-
biotic-antimycotic solution (Invitrogen Corporation).
Bone marrow cells were plated at a density of 20 × 10
6
per 9.6 cm
2 in MSC media at 37°C in 5% CO2 as pre-
viously described [21]. The non-adherent population
was removed after 72 hours, and the adherent cells were
washed with fresh media and cultured for 7 days. The
resulting adherent cells were harvested by incubating
with 0.25% trypsin (Invitrogen Corporation) followed by
gentle scraping. By means of negative selection via
immunomagnetic column (Miltenyi Biotec, Auburn, CA,
USA), cells negative for CD11b (eBioscience, San Diego,
CA, USA) and CD45 (eBioscience) were placed back
into culture. A homogenous cell phenotype was con-
firmed on the basis of the expression of CD29, CD44,
and Sca1 and the absence of hematopoietic (CD45,
CD14, and CD11b) markers. Prior to use, cells had been
passaged from one to four times.
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All studies were approved by the Institutional Review
Board of the University of Illinois. hdpPSCs were iso-
lated from the decidua parietalis dissected from placen-
tal membranes after normal vaginal delivery at term, as
previously described in detail [22]. Human placenta tis-
sue was obtained from the Human Female Reproductive
Tissue bank in the Center for Women’s Health and
Reproduction at the University of Illinois at Chicago.
Cells were cultured in RPMI-1640 medium supplemen-
ted with 10% heat-inactivated and charcoal-stripped
fetal bovine serum, 0.1 mM sodium pyruvate, and 1%
penicillin/streptomycin. At confluence, cells were trypsi-
nized, propagated, and used for experiments in passage
numbers three to five.
Recombinant sAPP
sAPPa (Sigma-Aldrich) was used at 10 nM concentra-
tions unless otherwise indicated (dissolved in phos-
phate-buffered saline, or PBS).
Conditioned media
Neurosphere media was conditioned by plating 3 × 10
5
NPCs in each well of a 12-well plate in 500 μLo fc o m -
plete media. After 1 hour, media was removed and spun
at 1,000g for 10 minutes to remove any cells or debris.
For depletion of sAPP, conditioned media was pre-
cleared with protein A-agarose beads (Pierce, Rockford,
IL, USA) and then incubated overnight at 4°C with
22C11 antibodies against the N-terminus of APP or IgG
antibodies (Millipore Corporation, Billerica, MA, USA)
as a control. Protein A-agarose beads were added for 30
minutes, the mixture was spun at 4,000 revolutions per
minute (rpm) for 3 minutes, and the supernatant was
used as depleted media. Regular conditioned media was
subjected to the same process without antibody incuba-
tion as a control. All media was filtered through a 0.22-
mm filter prior to addition.
Detection of sAPP
For the detection of soluble APP from brain lysates,
protein was extracted in immunoprecipitation buffer
containing 150 mM NaCl, 50 mM Tris-Cl, 5 mM ethy-
lenediaminetetraacetic acid (EDTA), 1% Triton-X 100,
0.5% sodium deoxycholate, protease inhibitor cocktail,
and 250 μM phenylmethylsulfonyl fluoride (PMSF). To
remove full-length APP, protein samples were immuno-
depleted by using 369 antibodies against the C-terminus
of APP (a gift from Sangram S Sisodia, The University
of Chicago). Briefly, samples were precleared with 50 μL
of immobilized protein A-agarose beads (Pierce) at 4°C
for 30 minutes. Samples were centrifuged at 4,000 rpm
for 3 minutes, and the pellet was discarded. To the
supernatant, 5 μL of 369 antibody was added and
incubated overnight at 4°C. The next morning, 50 μLo f
immobilized protein A was again added for 30 minutes
at 4°C and spun at 4,000 rpm for 3 minutes. The pellet
contains the full-length APP-369 antibody complex, and
the supernatant was probed for sAPP by using 22C11
antibodies raised against the N-terminus of APP (Milli-
pore Corporation).
Neurosphere formation (clonogenic) assay
Briefly, neurospheres were singly dissociated by
mechanical dissociation and plated at 1,000 cells per
well onto 96-well plates. For matrix-metalloproteinase
(MMP) inhibitor experiments, cells were then treated
with the indicated molar concentration of GM6001 or
GM6001 negative control (Millipore Corporation) and
the indicated molar concentrations of sAPP or condi-
tioned media. If not otherwise indicated, 1 μM
GM6001 and negative control inactive inhibitor (NC)
were used. Cells were treated every 72 hours for 10
days. After 10 days in culture, neurospheres were
counted under an inverted light microscope, and the
average neurosphere diameter was calculated from 25
randomly assigned squares of the grid by using a Zeiss
AX10 microscope (Carl Zeiss Ltd., Hertfordshire, UK)
and StereoInvestigator software (MBF Bioscience, Will-
iston, VT, USA). After sphere size determination, cells
were singly dissociated with a p200 pipette and
counted with a hemocytometer. The remaining cells
were placed onto Matrigel-coated chamber slides for
30 minutes and then fixed in 4% paraformaldehyde for
30 minutes for immunocytochemistry. Briefly, cells
were washed four times in Tris-buffered saline (TBS)
and then placed into blocking solution (5% normal
donkey serum, 0.25% Triton-X 100 in TBS) for 30
minutes at room temperature. Next, cells were incu-
bated in primary antibodies-mouse anti-nestin (1:100;
Millipore Corporation) and goat anti-Sox2 (1:200;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA)-
in TBS containing 0.25% Triton-X 100 for 1 hour at
room temperature. After primary antibodies, cells were
again incubated in blocking solution for 30 minutes at
room temperature before secondary antibody incuba-
tion-anti-goat cy5 (1:250; Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA, USA) and anti-
mouse cy3 (1:500; Jackson ImmunoResearch Labora-
tories, Inc.)-in TBS with 0.25% Triton-X 100 for 30
minutes at room temperature in the dark. Cells were
then washed four times in TBS and incubated for 5
minutes with DAPI (4’-6-diamidino-2-phenylindole)
(1:50,000; Invitrogen Corporation) at room tempera-
ture in the dark. Cells were then washed three times
and mounted with polyvinyl alcohol-DABCO mounting
solution. Cell counts were made by means of StereoIn-
vestigator software version 8 (MBF Bioscience).
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MSC or hdPSC were trypsinized for 5 to 10 minutes
with 0.05% trypsin, collected after trypsin inactivation,
and spun at 500g for 5 minutes. Pellets were then disso-
ciated and plated at 1,000 cells per well in 96-well
plates. Cells were then treated with the indicated molar
concentration of GM6001 or GM6001 negative control
(Millipore Corporation) and the indicated molar concen-
trations of sAPP. After 3 days in culture, cells were tryp-
sinized for 5 to 10 minutes, spun, and counted with a
hemocytometer.
Brain tissue for biochemistry and immunohistochemistry
Experiments using animals were performed according to
guidelines of the National Institutes of Health and the
University of Illinois at Chicago Institutional Animal
Care and Use Committee. The APP knockout [APP(-/-)]
model has been described previously [23,24]. Briefly, the
authors generated the mice through homologous recom-
bination in embryonic stem cells. Mice heterozygous for
APP expression were cross-mated and APP(+/+) (APP
wild-type), APP(+/-), and APP(-/-) resulted from this
breeding. Our colony is maintained via group housing
(fewer than five mice per cage) in a barrier facility
under a 14:10 light/dark cycle with free access to food
and water. Animal care and procedures were conducted
according to the National Institutes of Health Guide for
the Care and Use of Laboratory Animals [25].
Brain tissue processing
For in vivo immunohistochemical staining, male APP
(+/+) mice from 3 to 5 months old were used. All mice
were anesthetized with a mixture of ketamine and xyla-
zine and transcardially perfused with 100 mL of ice-cold
PBS. The brains were then removed and halved in the
sagittal plane. The left half was immediately placed into
4% paraformaldehyde on ice. From the right half of the
brain, the following regions were dissected for biochem-
ical analysis and immediately placed into Eppendorf
tubes on dry ice: SVZ, hippocampus, olfactory bulb,
frontal cortex, and cerebellum.
Immunohistochemistry
Left hemibrains from PBS-perfused mice were post-fixed
in 4% paraformaldehyde for 3 days and stored in 30%
sucrose at 4°C. Hemibrains were sectioned sagittally at
50 μmb yu s i n gam i c r o t o m ea n dp l a c e di n t oc r y o p r e -
servent (47.6% PBS, 28.57% ethylene glycol, and 25%
glycerin vol/vol). Sections were blocked by using a solu-
tion containing 0.25% vol/vol Triton-X 100 (Sigma-
Aldrich) and 5% vol/vol Normal Donkey Serum (Jackson
ImmunoResearch Laboratories, Inc.) in TBS. The follow-
ing antibodies were used: Dlx-2 (1:200; Millipore Cor-
poration), nestin (1:100; Millipore Corporation), Sox2
(1:100; Santa Cruz Biotechnology, Inc.), ADAM10
(1:200; Millipore Corporation), and APP (22C11; Milli-
pore Corporation and A8717; Sigma-Aldrich). Floating
sections were incubated in primary antibodies for 72
hours at 4°C before continuing with blocking, biotin
conjugation (Jackson ImmunoResearch Laboratories,
Inc.), and secondary antibody incubation (cy2 Streptavi-
din, anti-mouse cy3, anti-goat cy5, and anti-rabbit cy5;
Jackson ImmunoResearch Laboratories, Inc.).
Western blotting
Protein extraction from brain tissue was performed in
lysis buffer containing 1X TNE, 50 mM Tris, 150 mM
NaCl, 5 mM EDTA, protease inhibitor cocktail (Sigma-
Aldrich), and 100 mM PMSF. Quantification of protein
was performed by using the bicinchoninic acid (BCA)
method (Pierce), and equal amounts of protein were
subjected to direct immunoblotting. For the extraction
of protein from neurosphere, mesenchymal, and Human
decidua parietalis placenta stem cells cultures, a lysis
buffer containing 150 mM NaCl, 50 mM Tris-Cl, 5 mM
E D T A ,1 %T r i t o n - X1 0 0 ,0 . 5 %s o d i u md e o x y c h o l a t e ,
protease inhibitor cocktail, and 250 μM PMSF was used.
For quantification, at least three cultures were used.
Erk and Akt signaling
To assay phosphorylation of Erk and Akt, neurospheres
were singly dissociated and plated at 5 × 10
5 cells per
well in a six-well plate in Earle’s balanced salt solution
(Sigma-Aldrich) and treated immediately with 1 μM
GM6001 or GM6001 negative control. After 1-hour
incubation at 37°C, one of the GM6001-treated groups
was subsequently treated with 10 nM recombinant
sAPPa (Sigma-Aldrich) for 15 minutes before all groups
were lysed in ROLB buffer: 10 mM HEPES, pH 7.4,
0.5% Triton X-100, 80 mM b-glycerophosphate, 50 mM
sodium fluoride, 2 mM sodium orthovanadate, 100 nM
staurosporine, 100 nM K252a, 50 nM okadaic acid, 50
nM microcystin, mammalian protease inhibitor cocktail
(Sigma-Aldrich), and phosphatase inhibitor cocktail II
(Calbiochem, now part of EMD Biosciences, Inc., San
Diego, CA, USA) in water. After lysis, protein quantifi-
cation was performed by using the BCA method
(Pierce), and equal amounts of protein were run on
Tris-glycine gels and transferred to nitrocellulose mem-
branes. For blocking and antibodies, we employed a
solution of 0.05% vol/vol Tween, 10% wt/vol milk, and
0.1% wt/vol BSA (Sigma-Aldrich) in TBS. The following
antibodies were used: pErk (1:500; Santa Cruz Biotech-
nology, Inc.), Erk (1:1,000; Santa Cruz Biotechnology,
Inc.), pAkt (1:1,000; Cell Signaling Technology, Inc.,
Danvers, MA, USA), and Akt (1:500; Cell Signaling
Technology, Inc.). (N = 3 for Erk and Akt Western blot
quantification.)
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sAPPa rescues proliferation of neural progenitor cells
after treatment with a matrix-metalloproteinase and
ADAM inhibitor
To examine the role of sAPPa in NPC proliferation and
the significance of a-secretase cleavage of APP in this
process, NPCs isolated from the SVZ of adult mice were
treated with GM6001, a potent broad-spectrum hydro-
xamic acid-based inhibitor of MMPs and ADAMs which
has been shown to decrease levels of sAPP and sAPLP2
[11]. First, using Western blot analysis, we confirmed
that levels of sAPP are reduced in the conditioned
media of NPCs treated with GM6001 (Figure 1a, b).
Next, we singly dissociated NPCs and treated them with
either inactive inhibitor (NC) or GM6001 or with
GM6001 and sAPPa in a neurosphere formation assay.
We observed that treatment of neurosphere culture with
GM6001 significantly reduced proliferation of NPCs in a
dose-dependent manner (Figure 1c). Inhibition of NPC
proliferation could be rescued by the addition of recom-
binant sAPPa (Figure 1c), suggesting that sAPPa is suf-
ficient for the induction of NPC proliferation. To
further characterize the effect of sAPPa on NPC prolif-
eration, we repeated the clonogenic assay, treated singly
dissociated NPCs with NC or GM6001 or with GM6001
and sAPPa, and determined the number of neuro-
spheres generated, their diameter, and the total number
of NPCs (Figure 1d-f). We observed that, after treatment
with GM6001, there were significant reductions in the
diameter of neurospheres (Figure 1e) and the total num-
ber of NPCs observed in the cultures (Figure 1d) but
not a significant reduction in the number of clones (Fig-
ure 1f), suggesting that treatment with GM6001 affects
NPC proliferation without affecting clone formation
capability. Likewise, treatment of neurosphere cultures
with GM6001 and sAPPa significantly rescued impaired
neurosphere diameter and total number of NPCs with-
out affecting the number of neurospheres (Figure 1d-f).
To determine whether recovery of NPC proliferation by
sAPPa occurs in a dose-dependent manner, sAPPa was
added to neurosphere culture at a concentration range
of 100 pM to 100 nM. sAPPa recovered NPC prolifera-
tion after GM6001 treatment in a concentration as low
as 100 pM. Rescue of NPC proliferation increased as a
function of sAPPa dose and was maximal at 10 nM
(Figure 1g). Taken together, these data suggest that a-
secretase cleavage of APP is an important event in NPC
cell cycle control and that sAPPa regulates NPC
proliferation.
To determine the subpopulation of NPCs affected by
GM6001 inhibition and recovered by sAPPa,s i n g l yd i s -
sociated NPCs treated with GM6001 or GM6001 +
sAPPa were allowed to form neurospheres in a clono-
g e n i ca s s a ya sb e f o r ea n dt h e ni m m u n o l a b e l e dw i t h
antibodies raised against nestin, an intermediate filament
protein expressed in stem and progenitor cells [26], and
Sox2, a transcription factor expressed in neural stem
cells (NSCs) and NPCs of the adult brain [27]. We show
that the number of nestin
+Sox2
+ cells was significantly
reduced after treatment with GM6001, and their num-
ber was fully recovered after addition of sAPPa (Figure
2a-c, 2e, f), suggesting that sAPPa affects the prolifera-
tion of both NSCs and NPCs. Thus, we proceeded to
examine whether sAPPa affects self-renewal of NSCs
(Figure 2d). For this purpose, secondary neurospheres
were singly dissociated and cultured at one cell per well
in 96-well plates, and the number of cells that generated
tertiary neurospheres was quantified. We show that
treatment of cells with GM6001 significantly reduced
the number of generated neurospheres but that the
addition of sAPPa significantly enhanced the number of
neurspheres generated (Figure 2d), suggesting that
sAPPa regulates both NSC self-renewal and NPC
proliferation.
sAPPa regulates neural progenitor cell proliferation in an
EGF- and bFGF-independent manner
To address whether sAPPa is a stand-alone proliferation
factor or its proliferative effect depends on other growth
factors, we first compared the ability of NPC-condi-
tioned media containing sAPPa to rescue NPC prolif-
eration with that of conditioned media depleted of
sAPPa.W eo b s e r v e dt h a tc o n d i t i o n e dm e d i ac o n t a i n i n g
sAPPa successfully rescued NPC proliferation but that
conditioned media depleted of sAPPa failed to do so
(Figure 3a). Next, we excluded proliferation factors
(namely, EGF and bFGF) from the proliferation medium
of NPCs and examined the rate of proliferation of cells
by measuring clone formation and size (Figure 3b). As
expected, neurosphere proliferation was reduced without
EGF and bFGF. Interestingly, treatment of these neuro-
spheres with GM6001 further reduced the extent of pro-
liferation, suggesting that factors aside from EGF and
bFGF regulate neurosphere proliferation (Figure 3b).
Importantly, the addition of soluble APPa recovered
GM6001-induced deficits in proliferation even without
EGF and bFGF, suggesting that sAPPa operates inde-
pendently of EGF and bFGF (Figure 3b). To determine
whether sAPPa operates synergistically to these growth
factors in regulation of neurosphere proliferation, we
quantified the effect of sAPPa in medium devoid of
EGF/bFGF and supplemented with GM6001 as well as
the effect of EGF/bFGF in a medium supplemented with
GM6001 and compared the effect on neurosphere dia-
meter with the effect of EGF/bFGF on neurosphere dia-
meter in medium supplemented with the negative
control for GM6001. We observed that the additive
effect of sAPPa in medium devoid of EGF/bFGF and
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bFGF in a medium supplemented with GM is greater
than the effect of EGF/bFGF in medium supplemented
with the negative control for GM, suggesting a synergis-
tic effect of sAPPa, EGF, and bFGF (Figure 3b).
sAPPa regulates the proliferation of adult stem cells of
non-neural origin
As APP is ubiquitously expressed and was shown to act
upon fibroblasts and thyroid epithelial cells [14,15], we
examined whether it regulates adult stem cells of non-
Figure 1 Soluble amyloid precursor protein alpha (sAPPa) ameliorates matrix-metalloproteinase inhibitor-induced proliferation deficits
in neural progenitor cells (NPCs). (a) Western blot analysis shows that levels of secreted sAPP are dramatically reduced in NPCs after treatment
with matrix-metalloproteinase inhibitor GM6001 (GM) when compared with NPCs treated with an inactive inhibitor (NC). Actin from cell lysate
was used as a control for protein load. (b) Optical density of expression intensity of sAPP normalized to actin. (c) NPC proliferation as assayed by
a clonogenic assay. Total number of NPCs after 10 days in culture is reduced by GM6001 in a dose-dependent manner. Red diamond indicates 1
μM NC, blue diamonds indicate GM6001, green diamond indicates 1 μM GM6001 + 10 nM sAPPa, and dotted line indicates the number of cells
originally plated. (d) Recombinant sAPPa (10 nM) can recover 1 μM GM6001-induced deficits in NPC proliferation as shown by a reduction in
the number of NPCs counted per neurosphere observed in a clonogenic assay. (e) Measure of neurosphere diameter of neurospheres formed
after a 10-day clonogenic assay in which NPCs were treated with 1 μM NC, 1 μM GM6001, or 1 μM GM6001 + 10 nM sAPPa. (f) The number of
neurospheres formed after a 10-day clonogenic assay in which NPCs were treated with 1 μM NC, 1 μM GM6001, or 1 μM GM6001 + 10 nM
sAPPa. (g) Dose response of sAPPa effect on NPC proliferation after inhibition with 1 μM GM6001 in a clonogenic assay. Red diamond indicates
1 μM NC, blue diamond indicates 1 μM GM6001, and green diamonds indicate recombinant sAPPa. Error bars represent standard error of the
mean. *P < 0.05, analysis of variance with post hoc analysis. A.U., arbitrary units.
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proliferation after inhibition of MMPs and ADAMs was
cell-autonomous to NPCs or applied to other stem cell
types. For this purpose, we examined the extent of pro-
liferation of MSCs after GM6001 treatment. As in
NPCs, GM6001 treatment reduced secreted levels of
sAPPa (Figure 4a, b) and significantly reduced prolifera-
tion of MSCs (Figure 4c) in a dose-dependent manner,
suggesting that MMP family members may play an
important role in the proliferation of MSCs. The addi-
tion of recombinant sAPPa significantly recovered MSC
proliferation (Figure 4c, d). Like in the NPCs, 100 pM
of sAPPa was sufficient to significantly rescue MSC pro-
liferation and enhance their proliferation in a dose-
dependent manner (Figure 4e). Taken together, these
results suggest that APP is expressed in MSCs and pro-
cessed by a-secretase activity to yield sAPPa that in
turn regulates the proliferation of MSCs. Next, we inves-
tigated the effect of a-secretase inhibition and sAPPa
on the proliferative activity of hdpPSCs. The effect of
GM6001 on hdpPSCs was similar to the one observed
with NPCs and MSCs (Figure 5). Treatment with
GM6001 significantly reduced levels of secreted sAPPa
concomitantly with hdpPSC proliferation (Figure 5a-c),
and this deficit was ameliorated by the addition of
recombinant sAPPa in a dose-dependent manner (Fig-
ure 5c-e). Taken together, these results suggest that
sAPPa is an essential proliferation factor of a variety of
adult stem cells of different origins and provides a func-
tional significance for the abundance of APP.
Figure 2 Soluble amyloid precursor protein alpha (sAPPa) acts on both neural stem cells and neural progenitor cells to enhance
proliferation. Singly dissociated cells derived from the neurosphere formation assay described in Figure 1 were immunostained for DAPI (a),
Sox2 (b), and Sox2/nestin (c,e). GM6001 (GM) not only reduced total cell number but significantly reduced populations of Sox2 and Sox2/nestin-
expressing cells. sAPPa rescued the total cell number by enhancing the proliferation of these populations (c). Representative images of Sox2/
nestin double-labeling are shown (e). (d) The effect of GM6001 on neural stem cell self-renewal. Primary neurospheres were dissociated, and a
single cell per well was cultured in a 96-well plate in the presence of NC, GM, or GM + sAPPa. The percentage of single cells that formed
secondary neurospheres is shown. Scale bars = 85 μm (upper panel), 50 μm (lower panel). (f) Representative images of neurosphere formation
assay showing the effect of varying concentrations of sAPPa on the size of GM6001-treated neurospheres. Error bars represent standard error of
the mean. *P < 0.05, analysis of variance with post hoc analysis. DAPI, 4’-6-diamidino-2-phenylindole.
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Page 7 of 15High levels of sAPP are expressed in the subventricular
zone of adult mice
To establish that sAPPa plays a role in proliferation of
NPCs in vivo, we examined expression levels of full-
length APP and sAPPa i nt h eS V Z ,S G L ,a n dan o n -
neurogenic region (cerebellum) of APP(-/-) and APP
(+/+) mice. For this purpose, we used antibodies
recognizing the N◯-terminus of APP (22C11), thus
recognizing both full-length APP and sAPPa.W es h o w
that levels of 22C11 are comparable in the SGL and
cerebellum with a trend of increased expression in the
SVZ (Figure 6a). To examine whether this trend is a
result of increased levels of sAPPa specifically, we
immunodepleted full-length APP from the protein
extract by using antibodies recognizing the carboxyl-
terminus of APP, thus not capturing sAPPa.W e
observed that levels of sAPPa were particularly high in
the SVZ of both APP(+/+) and APP(+/-) (Figure 6b-d).
These results support our notion that sAPPa plays a
major role in the SVZ.
To determine whether the NSC and NPC populations
that express APP resemble those observed in vitro in
neurosphere culture, we double-stained brain sections of
adult mice with antibodies raised against APP, Sox2,
nestin, and Dlx-2, the last of which is a homeobox pro-
tein expressed in transit-amplifying C cells of the adult
SVZ [28]. APP expression colocalized with all three
markers, suggesting that APP is expressed in NSCs and
transit-amplifying NPCs in the adult SVZ (Figure 6e).
ADAM10 is expressed in the subventricular zone and
hippocampus of adult mice
To examine whether high levels of sAPPa in the SVZ
reflect levels of a-secretase in this region, we examined
expression of ADAM10, recently shown to be a critical a-
secretase during brain development [13]. We show that
levels of ADAM10 are significantly higher in the SVZ
compared with the SGL (Figure 7a, b). In support of a cor-
relation between levels of sAPPa and ADAM10 is the
observation that ADAM10 levels are lower in the SVZ of
APP(-/-) compared with APP(+/+) (Figure 7a, c). To
examine whether ADAM10 is expressed in the same neu-
rogenic populations as APP, we immunostained brain sec-
tions with antibodies raised against ADAM10, nestin,
Sox2, and BrdU 24 hours after a single dose. We observed
that ADAM10 colocalizes with all three markers, suggest-
ing that, like APP, ADAM10 is expressed in NSCs and
transit-amplifying NPCs in the adult SVZ (Figure 7d, e).
sAPP regulates extracellular signal-regulated kinase
activity
The mitogen-activated protein (MAP) kinase pathway
plays an important role in the proliferation of NPCs
derived from the adult SVZ [29]. Treatment with sAPP
Figure 3 Soluble amyloid precursor protein alpha (sAPPa) enhances proliferation in an EGF/bFGF-independent manner. (a) Neural
progenitor cell (NPC)-conditioned media that has been immunodepleted of sAPP with 22C11 antibodies fails to recover GM6001-induced
proliferation deficits of NPCs, as assayed by neurosphere diameter in a neurosphere formation assay. In contrast, NPC-conditioned media
immunodepleted with control IgG antibodies successfully recovers NPC proliferation. (b) A neurosphere formation assay was performed without
growth factors (EGF and bFGF), and NPCs were treated with an inactive inhibitor (NC), GM6001 (GM), or GM6001 + recombinant sAPPa (GM+rec
sAPPa). The proliferative effect of sAPPa on GM6001-treated neurosphere (GM) in medium devoid of EGF/bFGF and the proliferative effect of
EGF/bFGF on GM6001-treated neurospheres are greater than the effect of EGF/bFGF on neurospheres treated with NC, suggesting a synergistic
effect of sAPPa and EGF/bFGF. Error bars represent standard error of the mean. *P < 0.01, analysis of variance with post hoc analysis. bFGF, basic
fibroblast growth factor; EGF, epidermal growth factor.
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Page 8 of 15has been shown to stimulate ERK signaling in PC-12 cells
[30], and SORLA-deficient mice showing enhanced APP
cleavage to sAPP and Ab display increased neurogenesis
and ERK signaling in hippocampal neurons [19]. There-
fore, we tested whether inhibition of MMP activity,
decreasing sAPPa production, would result in deficient
ERK signaling. For this purpose, NPCs were treated with
GM6001 as before and placed into Hank’s balanced salt
solution for 1 hour to remove any presence of exogenous
growth factor signaling. Western blot analysis reveals that
pERK is reduced approximately 25% in NPCs treated with
GM6001 (Figure 8a, b). To examine whether this reduc-
tion can be recovered by addition of sAPPa, we added
recombinant sAPPa prior to lysing the cells. Recombinant
sAPPa was able to reverse the deficits in ERK phosphory-
lation caused by GM6001 treatment (Figure 8a, b). To test
whether this effect was specific to ERK, we examined
another integral proliferation pathway known to respond
to sAPPa [31], protein kinase B (Akt). Phosphorylation of
Akt did not change significantly from negative control in
any of the groups tested (Figure 8c, d), suggesting that
sAPPa is associated specifically with ERK signaling.
Discussion
During the last two decades, there has been much inter-
est in unraveling the physiological role of APP, its
Figure 4 Soluble amyloid precursor protein alpha (sAPPa) can recover matrix-metalloproteinase inhibitor-induced deficits in
mesenchymal stem cell (MSC) proliferation. (a) Western blot analysis shows that levels of secreted sAPP are dramatically reduced in MSCs
after treatment with matrix-metalloproteinase inhibitor GM6001 (GM) when compared with MSCs treated with an inactive inhibitor (NC). Actin
from cell lysates was used as a protein-loading control. (b) Optical density of expression intensity of sAPP (a) normalized to actin. (c) MSC
proliferation as assayed by total cell number after 3 days in culture is significantly reduced by GM6001 in a dose-dependent manner. Red
diamond indicates 1 μM NC, blue diamonds indicate GM6001, green diamond indicates 1 μM GM6001 + 10 nM sAPPa, and dotted line
indicates the number of cells originally plated. (d) The number of MSCs counted after 3 days of 1 μM NC, 1 μM GM6001, or 1 μM GM6001 + 10
nM sAPPa treatment after original plating of 1,000 cells per well. (e) Dose response of sAPPa effect on proliferation of MSCs after 1 μM GM6001
addition. Red diamond indicates 1 μM NC, blue diamond indicates 1 μM GM6001, and green diamonds indicate recombinant sAPPa. Error bars
represent standard error of the mean. *P < 0.01, analysis of variance with post hoc analysis. A.U., arbitrary units.
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Page 9 of 15metabolites, and the physiological significance of its
multiple metabolic pathways. Here, we show that
sAPPa, a product of APP cleavage by a-secretase, is a
proliferation factor of NPCs in the adult brain, MSCs,
and hdpPSCs. This suggests an important role for
sAPPa as a proliferation factor of different stem cell
populations in the adult. The diversity of stem cells that
respond to sAPPa as a proliferation factor leads us to
suggest that sAPPa exerts its effect on a wide range of
stem cell populations. NPCs used in this study were
derived from the adult mouse brain. MSCs were isolated
from the bone marrow of adult mice, and hdpPSCs
were isolated from the decidua parietalis dissected from
placental membranes. All stem cell populations have
self-renewal capability. Whereas NPCs are capable of
differentiating into neurons or glia only, MSCs exhibit
multilineage potential into many mesodermal cell types
and possibly into endodermal and ectodermal cells as
well (reviewed in [32]). hdpPSCs are of human fetal ori-
gin and are thought to exhibit multilineage potential
[33].
These results provide functional significance for the
fact that APP is ubiquitously expressed and is highly
conserved in evolution (reviewed in [34]). We show that
sAPPa is a potent factor that can recover proliferation
of these stem cell populations after treatment with an
MMP inhibitor. The importance of our observations is
supported by studies reporting that the expression of
Figure 5 Soluble amyloid precursor protein (sAPP) can ameliorate proliferation deficits in Human decidua parietalis placenta stem
cells (hdpPSCs) induced by GM6001 (GM). (a) Western blot analysis shows that hdpPSCs treated with GM6001 secrete significantly less sAPP
compared with hdpPSCs treated with an inactive control (NC). Actin serves as a protein-loading control. (b) Optical density representation of
expression intensity of sAPP in Western blot shown in (a). (c) The number of hdpPSCs counted after 3 days of 1 μM NC, 1 μM GM6001, or 1 μM
GM6001 + 10 nM sAPPa treatment after original plating of 1,000 cells per well. (d) hdpPSC proliferation as assayed by total cell number after 3
days in culture is reduced by GM6001 in a dose-dependent manner. Red diamond indicates 1 μM NC, blue diamonds indicate GM6001, green
diamond indicates 1 μM GM6001 + 10 nM sAPPa, and dotted line indicates the number of cells originally plated. (e) Dose response of sAPPa
effect on proliferation of hdpPSCs after 1 μM GM6001 addition. Red diamond indicates 1 μM NC, blue diamond indicates 1 μM GM6001, and
green diamonds indicate recombinant sAPPa. Error bars represent standard error of the mean. *P < 0.05, analysis of variance with post hoc
analysis. A.U., arbitrary units.
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Page 10 of 15sAPPa can rescue behavioral and physiological deficits
of APP knockout mice, such as growth and brain weight
deficits, agenesis of the corpus callosum, and impaired
spatial learning associated with impaired long-term
potentiation, suggesting that sAPPa is sufficient for the
execution of APP function compromised in its absence
[35,36].
APLP1 and APLP2 have substantial homology to APP,
both within the ectodomain and particularly within the
cytoplasmic tail [37]. Support for functional redundancy
between APLP2 and APP/APLP1 comes from studies of
combined knockouts [38]. Cleavage of APLP1 and
APLP2 by a-secretase yields sAPLPa of unknown func-
t i o n ,w h i c hm a yp l a yar o l es i m i l a rt ot h a to fs A P P a in
NPC and other stem cell populations. As we cannot
exclude a potential functional redundancy between
sAPPa and sAPLP2a, we avoid a potential compensa-
tory effect of sAPLPa i nt h ep r e s e n ts t u d yb yu s i n gt h e
GM6001 MMP inhibitor that inhibits APLP1,2 cleavage
by a-secretase as well. Expression levels of sAPPa were
particularly high in the SVZ. That may suggest that
NPC proliferation is differentially regulated in the two
neurogenic microenvironments in the adult brain [39]
(and that sAPPa plays an important role in the SVZ
specifically) or simply reflect the fact that the neuro-
genic population is larger in the SVZ. Expression levels
of the a-secretase, ADAM10, are significantly higher in
the SVZ compared with the dentate gyrus or to the SVZ
of APP(-/-), suggesting a correlation between a-secre-
tase and sAPPa in the neurogenic regions. Like in the
Figure 6 Amyloid precursor protein (APP) is expressed in neural stem cells and neural progenitor cells of the adult subventricular
zone (SVZ). (a) Western blot analysis shows higher expression levels of APP in the SVZ of APP(+/+) and APP(+/-) mice compared with the
hippocampus and cerebellum. (b) Levels of sAPP are dramatically higher in the SVZ of APP(+/+) and APP(+/-) mice compared with the
hippocampus and cerebellum. Optical density of expression level of APP (c) and sAPP (d) in Western blotting shown in (a). (e) Representative
confocal images of APP staining in brain sections: Top panels: APP staining in the SVZ of APP(+/+) (left) and APP(-/-) (right) mice. Middle and
bottom panels: High-power images of APP colocalization with Sox2 (middle left), nestin (middle right), and Dlx-2 (bottom) in the SVZ of APP
(+/+) mice. Error bars represent standard error of the mean. *P < 0.009 (c), *P < 0.01 (d), analysis of variance with post hoc analysis. Scale bar =
250 μm. A.U., arbitrary units.
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Page 11 of 15case of sAPPa, the higher level of ADAM10 expression
in the SVZ may be a reflection of the greater population
of NSCs and NPCs residing in the SVZ. While GM6001
inhibited a-secretase activity in NPCs, MSCs, and
hdpPSCs, we cannot exclude the possibility that the
identity of the dominant a-secretase in each one of
these stem cell populations is different, representing a
different member of the ADAM family, each of which is
differentially expressed in a tissue- or niche-specific
manner.
Finally, we provide an insight into the mechanism by
which sAPPa exerts its proliferative effect in NPCs. We
show that it acts in an EGF- and bFGF-independent
manner. It has been suggested that, because of the pre-
sence of a heparin-binding domain adjacent to the puta-
tive growth factor domain in APP [40] and the presence
of sAPP-binding sites on EGF-responsive NPCs [18],
signaling of sAPP may involve other factors (such as
EGF) which also can interact with heparin. Our results
suggest that any interaction of sAPPa and EGF or bFGF
is not necessary for the proliferation-related functions of
the molecule. Furthermore, we show that sAPPa signal-
ing is associated with ERK/MAP kinase signaling.
Increased phosphorylation of ERK is indicative of signal-
ing through the MAP kinase pathway. In NPCs, ERK
signaling is crucial for carbachol-induced increases in
DNA synthesis [41], inhibiting MAP kinase signaling
decreases BrdU incorporation after heparin-binding EGF
activation [42], and MEK 1 and 2 inhibitor, U0126, inhi-
bits proliferation after hypoxia/reoxygenation [43]. All of
these factors point to ERK/MAP kinase as a critical
pathway in the proliferation of NPCs. Another critical
pathway involved in proliferation of NPCs, Akt [41-44],
was not activated by sAPPa in vitro. Previous investiga-
tions using pharmaceutical inhibitors of either the ERK/
MAP kinase pathway or the Akt/PI3-K pathway suggest
Figure 7 Enhanced levels of ADAM10 in the subventricular zone (SVZ) of adult mice. (a) Expression of the a-secretase ADAM10 is high in
the SVZ compared with the hippocampus of APP(+/+) and APP(+/-) mice, suggesting a correlation with sAPPa levels. (b) Quantification of four
Western blots showing higher ADAM10 levels in the SVZ compared with the hippocampus. (c) Quantification of four Western blots showing that
ADAM10 expression is higher in APP(+/+) SVZ compared with that of the APP(-/-). (d) Representative images of ADAM10 colocalized with Sox2
and nestin in the adult SVZ. Scale bar = 125 μm. (e) Representative images of ADAM10 colocalized with BrdU after a single injection 24 hours
prior to sacrifice. Error bars represent standard error of the mean. *P < 0.001 (b), *P < 0.01 (c), Student t test. Scale bar = 250 μm. ADAM, a
disintegrin and metalloproteinase; APP, amyloid precursor protein; LV, lateral ventricle; sAPPa, soluble amyloid precursor protein alpha.
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Page 12 of 15that PI3-K inhibition results in both self-renewal deficits
and proliferation decline whereas MAP-kinase inhibition
affected proliferation only [45].
Conclusions
I ns u m m a r y ,w ep r o v i d ee v i d e n c et h a t ,b ys i g n a l i n g
through MAP kinase pathways, the evolutionarily con-
served sAPPa regulates the proliferation of adult stem
cells originating from different germ layers. Future stu-
dies should determine whether a reduction in a-secre-
tase activity or in sAPPa production or in both
contributes to the aging of these stem cell populations.
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